glutamic acid and cp 101,606

glutamic acid has been researched along with cp 101,606 in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chenard, B; Collins, M; Ducat, M; Menniti, F; Shalaby, I; White, F	1
Aizenman, E; Brimecombe, JC; Gallagher, MJ; Lynch, DR	1
Shuaib, A; Wang, CX	1
Gogas, KR	1
Hansen, KB; Ogden, KK; Traynelis, SF; Yuan, H	1

Reviews

2 review(s) available for glutamic acid and cp 101,606

Article	Year
NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Current drug targets. CNS and neurological disorders, 2005, Volume: 4, Issue:2 Topics: Animals; Brain; Brain Ischemia; Conotoxins; Drug Design; Excitatory Amino Acid Antagonists; Felbamate; Glutamic Acid; Humans; Neuroprotective Agents; Phenylcarbamates; Piperidines; Propylene Glycols; Protein Conformation; Rats; Receptors, N-Methyl-D-Aspartate	2005
Glutamate-based therapeutic approaches: NR2B receptor antagonists. Current opinion in pharmacology, 2006, Volume: 6, Issue:1 Topics: Animals; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Huntington Disease; Pain; Phenols; Piperidines; Protein Conformation; Receptors, N-Methyl-D-Aspartate	2006

Article

Year

NMDA/NR2B selective antagonists in the treatment of ischemic brain injury.

Current drug targets. CNS and neurological disorders, 2005, Volume: 4, Issue:2

Topics: Animals; Brain; Brain Ischemia; Conotoxins; Drug Design; Excitatory Amino Acid Antagonists; Felbamate; Glutamic Acid; Humans; Neuroprotective Agents; Phenylcarbamates; Piperidines; Propylene Glycols; Protein Conformation; Rats; Receptors, N-Methyl-D-Aspartate

2005

Glutamate-based therapeutic approaches: NR2B receptor antagonists.

Current opinion in pharmacology, 2006, Volume: 6, Issue:1

Topics: Animals; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Huntington Disease; Pain; Phenols; Piperidines; Protein Conformation; Receptors, N-Methyl-D-Aspartate

2006

Other Studies

3 other study(ies) available for glutamic acid and cp 101,606

Article	Year
CP-101,606, a potent neuroprotectant selective for forebrain neurons. European journal of pharmacology, 1997, Jul-23, Volume: 331, Issue:2-3 Topics: Animals; Autoradiography; Binding Sites; Cells, Cultured; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycine; Kinetics; Neurons; Neuroprotective Agents; Pipecolic Acids; Piperidines; Prosencephalon; Rats; Receptors, N-Methyl-D-Aspartate; Stereoisomerism	1997
An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:2 Topics: Animals; Arginine; CHO Cells; Cricetinae; Dizocilpine Maleate; Dopamine Antagonists; Electrophysiology; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Iodine Radioisotopes; Piperidines; Point Mutation; Receptors, N-Methyl-D-Aspartate	1998
Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors. Neuron, 2014, Mar-05, Volume: 81, Issue:5 Topics: Animals; Dimerization; Excitatory Amino Acid Antagonists; Glutamic Acid; HEK293 Cells; Humans; Oocytes; Patch-Clamp Techniques; Piperidines; Protein Binding; Rats; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Sulfonamides; Trace Elements; Xenopus laevis; Zinc	2014